Bristol-Myers Squibb Company: BofA Global Research cuts price objective to $66 from $71
BMY•BofA Global Research cut its price objective for Bristol-Myers Squibb to $66 from $71.
BMY•BMY•BMY•BofA Global Research cut its price objective for Bristol-Myers Squibb to $66 from $71.
